Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chairman, President and CEO, Director
-
Stock Symbol
-
CRL on NYSE
James C. Foster - trading volume in the past year for Charles River Laboratories International, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
186K |
$37M |
$199.36 |
Aug 12, 2024 |
Direct |
|
|
Stock Options (Right to Buy) |
24.9K |
$5.18M |
$208.44 |
May 31, 2024 |
Direct |
Common Stock |
|
Common Stock |
20K |
$3.99M |
$199.36 |
Aug 12, 2024 |
2024 GRAT |
|
|
Common Stock |
10K |
$1.99M |
$199.36 |
Aug 12, 2024 |
Held By Spouse |
|
|
Common Stock |
9.79K |
$1.95M |
$199.36 |
Aug 12, 2024 |
2023 GRAT |
|
|
Common Stock |
7.58K |
$1.51M |
$199.36 |
Aug 12, 2024 |
2022 GRAT |
|
|
Common Stock |
2.25K |
$449K |
$199.36 |
Aug 12, 2024 |
By Trust |
|
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.